These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 34104846)

  • 21. Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(12):1-97. PubMed ID: 23074482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stent thrombosis in the era of drug eluting stents.
    Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA
    Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerated endothelialization with a polymer-free sirolimus-eluting antibody-coated stent.
    Yu Z; Zhu H; Lü S; Yang X
    J Mater Sci Mater Med; 2013 Nov; 24(11):2601-9. PubMed ID: 23975333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
    Gherasie FA; Valentin C; Busnatu SS
    J Pers Med; 2023 Apr; 13(5):. PubMed ID: 37240923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inception to actualization: next generation coronary stent coatings incorporating nanotechnology.
    Tan A; Farhatnia Y; de Mel A; Rajadas J; Alavijeh MS; Seifalian AM
    J Biotechnol; 2013 Mar; 164(1):151-70. PubMed ID: 23376617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
    van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary Investigation on Efficacy and Safety of Substance P-Coated Stent for Promoting Re-Endothelialization: A Porcine Coronary Artery Restenosis Model.
    Park DS; Oh S; Jin YJ; Na MH; Kim M; Kim JH; Hyun DY; Cho KH; Hong YJ; Kim JH; Ahn Y; Hermida-Prieto M; Vázquez-Rodríguez JM; Gutiérrez-Chico JL; Mariñas-Pardo L; Lim KS; Park JK; Byeon DH; Cho YN; Kee SJ; Sim DS; Jeong MH
    Tissue Eng Regen Med; 2024 Jan; 21(1):53-64. PubMed ID: 37973692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanomaterial coatings applied on stent surfaces.
    Bagheri M; Mohammadi M; Steele TW; Ramezani M
    Nanomedicine (Lond); 2016 May; 11(10):1309-26. PubMed ID: 27111467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary stent thrombosis: current insights into new drug-eluting stent designs.
    Kim HK; Jeong MH
    Chonnam Med J; 2012 Dec; 48(3):141-9. PubMed ID: 23323218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy.
    Curcio A; Torella D; Indolfi C
    Circ J; 2011; 75(6):1287-96. PubMed ID: 21532177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk prediction of in-stent restenosis among patients with coronary drug-eluting stents: current clinical approaches and challenges.
    Sakamoto A; Sato Y; Kawakami R; Cornelissen A; Mori M; Kawai K; Fernandez R; Fuller D; Gadhoke N; Guo L; Romero ME; Kolodgie FD; Virmani R; Finn AV
    Expert Rev Cardiovasc Ther; 2021 Sep; 19(9):801-816. PubMed ID: 33470872
    [No Abstract]   [Full Text] [Related]  

  • 32. Vascular remodeling after coronary stent implantation.
    Vorpahl M; Virmani R; Ladich E; Finn AV
    Minerva Cardioangiol; 2009 Oct; 57(5):621-8. PubMed ID: 19838152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress in treatment by percutaneous coronary intervention: the stent of the future.
    Muramatsu T; Onuma Y; Zhang YJ; Bourantas CV; Kharlamov A; Diletti R; Farooq V; Gogas BD; Garg S; García-García HM; Ozaki Y; Serruys PW
    Rev Esp Cardiol (Engl Ed); 2013 Jun; 66(6):483-96. PubMed ID: 24776051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stable Titania Nanostructures on Stainless Steel Coronary Stent Surface for Enhanced Corrosion Resistance and Endothelialization.
    Mohan CC; Cherian AM; Kurup S; Joseph J; Nair MB; Vijayakumar M; Nair SV; Menon D
    Adv Healthc Mater; 2017 Jun; 6(11):. PubMed ID: 28272784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, preparation and performance of a novel drug-eluting stent with multiple layer coatings.
    Hu T; Lin S; Du R; Fu M; Rao Q; Yin T; Huang Y; Wang G
    Biomater Sci; 2017 Aug; 5(9):1845-1857. PubMed ID: 28676873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-eluting stent: the emerging technique for the prevention of restenosis.
    Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
    Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evolving impact of microfabrication and nanotechnology on stent design.
    Caves JM; Chaikof EL
    J Vasc Surg; 2006 Dec; 44(6):1363-8. PubMed ID: 17145446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress and prospects of endothelial progenitor cell therapy in coronary stent implantation.
    Lan H; Wang Y; Yin T; Wang Y; Liu W; Zhang X; Yu Q; Wang Z; Wang G
    J Biomed Mater Res B Appl Biomater; 2016 Aug; 104(6):1237-47. PubMed ID: 26059710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.
    Mehilli J; Byrne RA; Tiroch K; Pinieck S; Schulz S; Kufner S; Massberg S; Laugwitz KL; Schömig A; Kastrati A;
    J Am Coll Cardiol; 2010 Jun; 55(24):2710-6. PubMed ID: 20226618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial.
    Wijns W; Steg PG; Mauri L; Kurowski V; Parikh K; Gao R; Bode C; Greenwood JP; Lipsic E; Alamgir F; Rademaker-Havinga T; Boersma E; Radke P; van Leeuwen F; Camenzind E;
    Eur Heart J; 2014 Oct; 35(40):2812-20. PubMed ID: 25106761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.